Evotec International
	Manufacturer of biopharmaceutical products. The company develops therapies for metabolic disorders based on model organisms and stem cell expertise.
	['biomarker ', 'metabolic disorders', ' ', 'biopharmaceuticals services', '']
Alinea Pharmaceuticals
	Develop of therapeutics for the treatment of diabetes and other metabolic disorders. The company also commercialize pharmaceuticals for the treatment of diabetes and related metabolic disorders.
	['', 'diabetes treatment therapeutic', ' ', 'metabolic disorder treatment', ' ', 'diabetes treatment pharmaceutical', '']
Maxia Pharmaceuticals
	Provider of non-dermatological applications of a patented library of compounds. The company focuses on small molecule drugs that target major diseases such as cancer and metabolic disorders.
	['', 'molecule drugs', ' ', 'metabolic disorders', ' ', 'cervical cancer', '']
Movetis
	Developer of drugs for the treatment of diseases in the gastrointestinal (GI) area. The company\'s products address GI disorders, such as severe chronic constipation, ascites, paediatric reflux, as well as severe forms of GI motility disorders, including refractory gastro-oesophageal reflux disease. Its lead product, Resolor, is used for the symptomatic treatment of chronic constipation in women.
	['', 'gastrointestinal treatment', ' ', 'GI disorder', ' ', 'paediatric reflux', ' ascite gastrointestinal  constipation ', 'paediatric reflux', ' ', 'GI motility', ' ', 'refractory gastro-oesophageal reflux', '']
Biophytis
	Developer of drugs for metabolic disorders and age-related diseases. The company develops nutraceuticals and drug candidates derived from active natural substances.
	['nutraceutical ', 'food supplement', ' ', 'metabolic disorder', ' ', 'drug candidate', '']
Paradigm Therapeutics
	Developer of drugs combining model genetics and bioinformatics. The company provides target identification and validation services based on gene knock out technology and in vivo pharmacology. The company has developed a drug discovery pipeline comprising targets and late stage pre-clinical projects in pain, CNS disorders, hormone dependent diseases such as prostate and breast cancer and metabolic diseases such as diabetes, hyperlipidemias, obesity and osteoporosis.
	['', 'hormone dependent diseases', ' bioinformatics ', 'model genetics', ' ', 'validation services', '']
MIGENIX
	Developer of drugs to treat or prevent infectious, degenerative and metabolic diseases. The company is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs for the prevention and treatment of major medical diseases and certain conditions with unmet medical need.
	['', 'commercial drug', ' ', 'disease control', ' ', 'metabolic diseases', ' infection']
Groove Biopharma
	Developer of therapeutics to affect cellular processes involving microRNAs. The companyâ€™s technology addresses nucleotide therapeutic drug discovery via modulation of cellular miRNA. Its technology platform presents potential for treating various diseases, including cancers, infectious disease, and metabolic disorders.
	['', 'nucleotide therapy', ' ', 'biotechnology service', ' ', 'microRNA therapeutic', ' ', 'medical services', '']
CareX
	Developer of drugs for metabolic disorders.
	['', 'metabolic disorder', ' ', 'metabolic disease treatment', ' ', 'obesity treatment', '']
Technologie BiolActis
	Developer of natural peptide mixtures for the treatment and prevention of diseases like lipid disorders, cardio-vascular disorders and metabolic syndrome. The company develops products for human wellness, concentrating on metabolic disorders and obesity-associated conditions weight management, systemic and local inflammation, hyperlipidemia, metabolic syndrome, hypertension, diabetes and cancer.
	['', 'peptide mixtures', ' ', 'metabolic syndrome', ' immunotherapy ', 'metabolic drug', ' ', 'nutraceutical drugs', '']
PRADAMA
	Developer of drugs for bone diseases and disorders.
	['', 'bone disease', ' ', 'bone disorder', ' ', 'bone drugs', '']
